Skip to main content
Clinical Trials/CTRI/2023/08/056430
CTRI/2023/08/056430
Not yet recruiting
Phase 3

Transcranial Direct Current Stimulation (tDCS) in Alzheimerâ??s Dementia (NEUROMOD-AD) Study: Efficacy and Follow up study of neuromodulation on Cognition and BPSD - Neuromod AD

Department of Health Research0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Health Research
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Health Research

Eligibility Criteria

Inclusion Criteria

  • Alzheimer disease diagnosed with NINDCS or DSM 5 criteria with MMSE score more than 16

Exclusion Criteria

  • 1\.Participants with unstable medical conditions, serious metabolic and/or cardiac diseases, alcoholism, focal neurological disorders (e.g., epilepsy, stroke, brain injury or tumor) and associated psychiatric disorders
  • 2\.Using hypnotics and benzodiazepines up to 2 weeks before the start of the study
  • 3\.With any condition (e.g., communication, sensory, or motor deficits) that could significantly interfere with the neuropsychological assessment
  • 4\.Exclusion criteria relating to contraindications of neurostimulation will be applied, following the safety guidelines: (a) using psychoactive drugs (b) having implanted metallic or electronic devices; (c) having a cardiac pacemaker, seizures, acute eczema under the electrodes; and (d) the presence of tumors, epilepsy, or substance abuse

Outcomes

Primary Outcomes

Not specified

Similar Trials